Pregnancy Clinical Trial
— TPPOfficial title:
Evaluation of Respecting the Circle of Life on Pregnancy Prevention Outcomes Among American Indian Adolescents
NCT number | NCT02904629 |
Other study ID # | 6670 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2016 |
Est. completion date | April 2022 |
Verified date | July 2022 |
Source | Johns Hopkins Bloomberg School of Public Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this research study is to evaluate a culturally tailored sexual and reproductive health intervention among American Indian (AI) youth. Specifically, the investigators aim to evaluate the impact of "Respecting the Circle of Life: Mind, Body and Spirit" on knowledge, attitude and behavioral outcomes associated with risk for unprotected sex, sexually transmitted infection (STI) and unintended pregnancy through a randomized controlled trial on the White Mountain Apache (WMA) reservation. The investigators will examine whether the RCL intervention effectively reduces risky sexual behavior among AI adolescents (11-19 years old), with long term goals of reducing teen pregnancy and incidence/prevalence of STIs. The evaluation will focus on well-established intermediate outcomes/risky sexual behaviors that predict long-term impact on teen pregnancy and STI incidence.
Status | Completed |
Enrollment | 1072 |
Est. completion date | April 2022 |
Est. primary completion date | April 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 11 Years and older |
Eligibility | Inclusion Criteria: - American Indian ethnicity - Membership in the White Mountain Apache community. (Although the investigators anticipate the vast majority of participants will be White Mountain Apache tribal members, study participation is open to all American Indian individuals who live on the Fort Apache Indian Reservation or on/near the border). - Participants ages 11+ must have parent/legal guardian consent - Adult participants must sign written informed consent Exclusion Criteria: - Inability to participate in full intervention or evaluation (e.g., planned move, residential treatment, etc.) - Unwilling to be randomized |
Country | Name | City | State |
---|---|---|---|
United States | Johns Hopkins Center for American Indian Health | Whiteriver | Arizona |
Lead Sponsor | Collaborator |
---|---|
Johns Hopkins Bloomberg School of Public Health |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Condom use at last sex as measured by the proportion of sexually active participants who report using a condom at last sex | Condom use at last sex among sexually active participants between intervention and controls groups at baseline, 3-month, 9-month, 12-month, 24-month, 36-month post-intervention | 3-month, 9-month, 12-month, 24-month, 36-month | |
Other | Number of sexual partners as measured by the mean number of sexual partners reported in the past 3 months | Number of sexual partners among sexually active participants, between intervention and control groups at baseline, 3-month, 9-month, 12-month, 24-month, 36-month post-intervention | 3-month, 9-month, 12-month, 24-month, 36-month | |
Other | Sexual activity without using a condom as measured by the proportion of participants who had sex without a condom in the past 3 months and the mean number of times reported having sex without a condom in the past 3 months | Sexual activity without using a condom among sexually active participants between intervention and control groups at baseline, 3-month, 9-month, 12-month, 24-month, 36-month post-intervention. | 3-month, 9-month, 12-month, 24-month, 36-month | |
Other | Contraceptive use as measured by the proportion of sexually active participants who had sex without birth control in the past 3 months and the mean number of times reported having sex without birth control in past 3 months | Contraceptive use among sexually active participants in past three months, by sexually active participants, between intervention and control groups at 3-month post-intervention. | 3-month | |
Other | Parental engagement as measured by the Parent-Adolescent Communication Scale: (Mean Score on 39-item Likert Scale) and the Parental Monitoring Scale: (Mean Score on a 6-item Likert Scale) | Parental engagement with youth participants (communication and monitoring) between intervention and control groups at baseline, 3-month, 9-month, 12-month, 24-month, 36-month post-intervention. | 3-month, 9-month, 12-month, 24-month, 36-month | |
Other | Risky sexual behaviors as measured by the proportion who report having unprotected sex in the past 3 months among participants who use alcohol and drugs | Risky sexual behavior in last 3 months among participants who use alcohol and drugs, between intervention and control groups. | 3-month | |
Other | Substance use during sex as measured by the proportion who use alcohol or drugs immediately prior to and/or during sex | Substance use immediately prior and/or during sex, among sexually active participants between intervention and control groups at baseline, 3-month, 9-month, 12-month, 24-month and 36-month post-intervention | 3-month, 9-month, 12-month, 24-month, 36-month | |
Primary | Condom use self efficacy as measured by the Condom Use Self-Efficacy Scale (range 1-5): Mean score on a 6-question Likert scale (1-5) | Mean difference in ability to correctly and consistently use condoms, between intervention and control groups at baseline, 3-month, 9-month, 12-month, 24-month, 36-month post-intervention. | 3-month, 9-month, 12-month, 24-month, 36-month | |
Secondary | Initiation of sexual activity as measured by the proportion of participants who report ever having sex | Delayed initiation of sexual activity between intervention and control groups at baseline, 3-month, 9-month, 12-month, 24-month, 36-month post-intervention. | 3-month, 9-month, 12-month, 24-month, 36-month | |
Secondary | Knowledge of sexual and reproductive health as measured by the mean score on a 44-question reproductive and sexual health knowledge survey | Change in knowledge score (range 0-100%) related to sexual and reproductive health, pregnancy and contraception between intervention and control groups at between baseline, 3-month, 9-month, 12-month, 24-month, 36-month post-intervention. | 3-month, 9-month, 12-month, 24-month, 36-month | |
Secondary | Condom use intention as measured by the proportion of participants who report they intend to use a condom at next sex | Change in intention to use a condom at next sex, between intervention and control groups at baseline, 3-month, 9-month, 12-month, 24-month, 36-month post-intervention | 3-month, 9-month, 12-month, 24-month, 36-month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02523755 -
Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia
|
Phase 4 |